291 related articles for article (PubMed ID: 31505648)
1. Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
Lagacé-Wiens PRS; Adam HJ; Poutanen S; Baxter MR; Denisuik AJ; Golden AR; Nichol KA; Walkty A; Karlowsky JA; Mulvey MR; Golding G; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv22-iv31. PubMed ID: 31505648
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
Zhanel GG; DeCorby M; Adam H; Mulvey MR; McCracken M; Lagacé-Wiens P; Nichol KA; Wierzbowski A; Baudry PJ; Tailor F; Karlowsky JA; Walkty A; Schweizer F; Johnson J; ; Hoban DJ
Antimicrob Agents Chemother; 2010 Nov; 54(11):4684-93. PubMed ID: 20805395
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
4. Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
Karlowsky JA; Adam HJ; Desjardins M; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i39-46. PubMed ID: 23587777
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
[TBL] [Abstract][Full Text] [Related]
6. Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11.
Lagacé-Wiens PR; Adam HJ; Low DE; Blondeau JM; Baxter MR; Denisuik AJ; Nichol KA; Walkty A; Karlowsky JA; Mulvey MR; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i23-9. PubMed ID: 23587775
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.
Karlowsky JA; Lagacé-Wiens PR; Simner PJ; DeCorby MR; Adam HJ; Walkty A; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2011 Jul; 55(7):3169-75. PubMed ID: 21537027
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011.
Wong PH; von Krosigk M; Roscoe DL; Lau TT; Yousefi M; Bowie WR
BMC Infect Dis; 2014 Oct; 14():393. PubMed ID: 25308184
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).
Sader HS; Castanheira M; Jones RN; Flamm RK
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):261-265. PubMed ID: 28069328
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
Adam HJ; Baxter MR; Davidson RJ; Rubinstein E; Fanella S; Karlowsky JA; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i31-7. PubMed ID: 23587776
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
[TBL] [Abstract][Full Text] [Related]
12. Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
Denisuik AJ; Karlowsky JA; Adam HJ; Baxter MR; Lagacé-Wiens PRS; Mulvey MR; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv64-iv71. PubMed ID: 31505647
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda.
Najjuka CF; Kateete DP; Kajumbula HM; Joloba ML; Essack SY
BMC Res Notes; 2016 Apr; 9():235. PubMed ID: 27113038
[TBL] [Abstract][Full Text] [Related]
14. 42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
Zhanel GG; Adam HJ; Baxter MR; Fuller J; Nichol KA; Denisuik AJ; Golden AR; Hink R; Lagacé-Wiens PRS; Walkty A; Mulvey MR; Schweizer F; Bay D; Hoban DJ; Karlowsky JA;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv5-iv21. PubMed ID: 31505641
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
Mao T; Zhai H; Duan G; Yang H
Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
[TBL] [Abstract][Full Text] [Related]
16. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
17. [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].
Asencio MÁ; Huertas M; Carranza R; Franco M; Castellanos J; Barberá JR; Conde Mdel C; Tenías JM
Rev Esp Quimioter; 2014 Dec; 27(4):261-8. PubMed ID: 25536430
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
Jean SS; Lee WS; Bai KJ; Yu KW; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):290-5. PubMed ID: 25600841
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of respiratory isolates of Enterobacteriaceae and Staphylococcus aureus in Italy: incidence and trends over the period 1997-1999.
Fontana R; Lo Cascio G; Ligozzi M; Friscia O; Oldoni T;
Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):854-63. PubMed ID: 11837636
[TBL] [Abstract][Full Text] [Related]
20. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
